Encompass Health Corporation (EHC) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$107.18
Price Target
$153.00
Target Range
$153.00 — $153.00
Analyst Rating
Buy
Forward P/E18.1x
Trailing P/E19.3x
Forward PEG1.27
Implied Growth-2.2%
Median Target$153.00
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$153
+42.8%
Consensus
$153
+42.8%
Bull Case
$153
+42.8%
Valuation Model TargetsConfidence: 60/100
Bear$80
Base$139
Bull$250
EHC Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Encompass Health Corporation (EHC) has a Wall Street consensus price target of $153.00, based on estimates from 26 covering analysts. With the stock currently trading at $107.18, this represents a potential upside of +42.8%. The company has a market capitalization of $10.66B.
Analyst price targets range from a low of $153.00 to a high of $153.00, representing a 0% spread in expectations. The median target of $153.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 21 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, EHC trades at a trailing P/E of 19.3x and forward P/E of 18.1x. The forward PEG ratio of 1.27 indicates reasonable valuation for growth. Analysts expect EPS to grow -2.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $138.51, with bear and bull scenarios of $79.59 and $250.47 respectively. Model confidence stands at 60/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+20.8%
Avg Forward P/E17.1x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 USPHU.S. Physical Therapy, Inc. | $897M | $59.00 | $102.00 | +72.9% | Buy | 20.6x | 12 |
 SEMSelect Medical Holdings Corporation | $2.0B | $16.44 | $18.00 | +9.5% | Hold | 13.1x | 13 |
 ENSGThe Ensign Group, Inc. | $10.2B | $174.30 | $222.33 | +27.6% | Buy | 23.2x | 13 |
 ACHCAcadia Healthcare Company, Inc. | $2.3B | $24.46 | $23.50 | -3.9% | Buy | 16.4x | 25 |
 UHSUniversal Health Services, Inc. | $10.7B | $170.56 | $231.50 | +35.7% | Hold | 7.3x | 43 |
 THCTenet Healthcare Corporation | $17.0B | $194.13 | $268.00 | +38.1% | Buy | 10.9x | 32 |
 HCAHCA Healthcare, Inc. | $95.9B | $429.17 | $527.45 | +22.9% | Buy | 14.2x | 46 |
 CYHCommunity Health Systems, Inc. | $408M | $2.90 | $2.93 | +1.2% | Hold | — | 37 |
 UNHUnitedHealth Group Incorporated | $335.6B | $369.74 | $385.43 | +4.2% | Buy | 20.2x | 52 |
 HUMHumana Inc. | $29.7B | $247.14 | $246.00 | -0.5% | Hold | 27.7x | 44 |
Upside Potential Comparison
USPHTHCUHSENSGHCASEMUNHCYHFull EHC Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See EHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEHC — Frequently Asked Questions
Quick answers to the most common questions about buying EHC stock.
What is the EHC stock price target for 2026?
The consensus Wall Street price target for EHC is $153, representing 42.8% upside from the current price of $107.18. With 26 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is EHC a buy, sell, or hold?
EHC has a consensus rating of "Buy" based on 26 Wall Street analysts. The rating breakdown is predominantly bullish, with 21 Buy/Strong Buy ratings. The consensus 12-month price target of $153 implies 42.8% upside from current levels.
Is EHC stock overvalued or undervalued?
With a forward P/E of 18.0974x, EHC trades at a relatively low valuation. The consensus target of $153 implies 42.8% appreciation, suggesting meaningful undervaluation.
How high can EHC stock go?
The most bullish Wall Street analyst has a price target of $153 for EHC, while the most conservative target is $153. The consensus of $153 represents the median expectation. Our quantitative valuation model projects a bull case target of $250 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover EHC stock?
EHC is heavily covered by Wall Street, with 26 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 20 have Buy ratings, 4 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the EHC stock forecast?
The 12-month EHC stock forecast based on 26 Wall Street analysts shows a consensus price target of $153, with estimates ranging from $153 (bear case) to $153 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $139, with bear/bull scenarios of $80/$250.
What is EHC's fair value based on fundamentals?
Our quantitative valuation model calculates EHC's fair value at $139 (base case), with a bear case of $80 and bull case of $250. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 60/100.
What is EHC's forward P/E ratio?
EHC trades at a forward P/E ratio of 18.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 19.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy EHC stock?
Wall Street analysts are very optimistic on EHC, with a "Buy" consensus rating and $153 price target (42.8% upside). 21 of 26 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do EHC price targets vary so much?
EHC analyst price targets range from $153 to $153, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $153 consensus represents the middle ground. Our model's $80-$250 range provides an independent fundamental perspective.